Vernalis Research - a Fully Owned Subsidiary of HitGen Inc -

Vernalis Research ("Vernalis"), a fully owned subsidiary of HitGen Inc., and Hannibal Innovation ApS ("Hannibal") are pleased to announce the creation of Dania Therapeutics ApS ("Dania") to discover

Related Keywords

China , Chengdu , Sichuan , Houston , Texas , United States , Cambridge , Cambridgeshire , United Kingdom , Copenhagen , Køavn , Denmark , Kim Andersen , Kristian Helin , Kostenloser Wertpapierhandel , Karin Absalonsen , Jin Li , Hamed Brodersen , University Of Copenhagen , Vernalis Research , Vernalis Rd Ltd , Institute Of Cancer Research , Hitgen Inc , Biotech Research Innovation Centre , Professor Kristian Helin At University Of Copenhagen , Hannibal Innovation Aps , Dania Therapeutics Aps , Professor Kristian Helin , Karl Agger , Wood Managing Director , Mike Wood Managing Director , Hitgen Chengdu , Fragment Based Drug , Structure Based Drug Design , Chief Executive Officer , Shanghai Stock Exchange , Cambridge United Kingdom , Cancer Research , Cell Biology Program , Memorial Sloan Kettering Cancer , Hannibal Innovation , Vernalis , Research , Bully , Wned , Ubsidiary , Titgen , Annibal , Innovation , Nnounce , Creation , Mania , Herapeutics ,